Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation

Pharmacotherapy

Volumn 23, Issue 1, 2003, Pages 57-63

  Wodlinger, Anna M ^a   Pieper, John A ^b  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; WARFARIN;

ANTICOAGULANT THERAPY; CARDIOVERSION; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEMODYNAMICS; HUMAN; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; SHORT SURVEY; SINUS RHYTHM; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; CLINICAL TRIALS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0037230732     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.1.57.31917     Document Type: Article

References (26)

1. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary - a report of the American College of Cardiology, American Heart Association task force on practice guidelines, and the European Society of Cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 2001;38:1231-65.
2. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001;119:S194-206.
3. Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969;23:208-16.
4. Weinberg DM, Mancini J. Anticoagulation for cardioversion of atrial fibrillation. Am J Cardiol 1989;63:745-6.
5. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or flutter. J Am Coll Cardiol 1992;19:851-5.
6. Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 1989;13:617-23.
7. Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol 1998;82:1545-7.
8. Goldman MJ. The management of chronic atrial fibrillation: indications and method of conversion to sinus rhythm. Prog Cardiovasc Dis 1959;2:465-79.
9. Corrado G, Tadeo G, Beretta S, et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation: a transesophageal echocardiographic study. Chest 1999;115:140-3.
10. Schlicht JR, Davis RC, Naqi K, Cooper W, Rao BV. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation. Arch Intern Med 1996;156:290-4.
11. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. Circulation 1995; 92:1954-68
12. Manning WJ, Silverman DI, Gordon SP, Krumholz HM, Douglas PS. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993;328:750-5.
13. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5 year study J Am Coll Cardiol 1995;25:1354-61.
14. Stoddard MF, Dawkins PR, Prince CR, Longaker RA. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 1995;129:1204-15.
15. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994;23:307-16.
16. Black IW, Fatkin D, Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: a multicenter study. Circulation 1994;89:2509-13.
17. The Steering and Publications Committees of the ACUTE Study, for the ACUTE Investigators. Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (the ACUTE multicenter study). Am J Cardiol 1998;81:877-83.
18. Klein AL, Grimm RA, Murray RD, et al, for the Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20.
19. Hirsch J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001;119:S64-94.
20. Murray RD, Deitcher SR, Shah A, et al. Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation. J Am Soc Echocardiogr 2001;14:200-8.
21. Roijer A, Eskilsson J, Olsson B. Transesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter: selection of a low-risk group for immediate cardioversion. Eur Heart J 2000;21:837-47
22. Bechtold H, Sawitzki H, Gunzenhauser D, Janssen D. Anticoagulation with low-molecular-weight heparin dalteparin in atrial fibrillation [abstr]. Eur Heart J 2000;21(suppl):8.
23. De Luca I, Sorina M, Del Salvatore B, de Luca L. A new therapeutic strategy for electrical cardioversion of atrial fibrillation. Ital Heart J 2001;2:831-40.
24. Koomen EM, ten-Berg JM, Hamraoui K, Gadellaa JCA, Jaarsma W. Usefulness of low-molecular-weight heparin for early transesophageal echocardiography-guided cardioversion in outpatients with atrial fibrillation or atrial flutter [abstr]. Eur Heart J 2000;21:557.
25. Stellbrink C. Anticoagulation for cardioversion using enoxaparin. Oral presentation at the European Society of Cardiology Congress, Berlin, Germany, August 31-September 4, 2002. Available from www.escardio.org. Accessed September 4, 2002.
26. Murray RD, Shah A, Jasper SE, et al. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study [online exclusive article]. Am Heart J 2000;139:e5. Available from www.mosby.com\ahj. Accessed November 6, 2002.